“The LOCATE study demonstrated that imaging with 18F fluciclovine PET/CT revealed one or more sites of disease recurrence in men with biochemically recurrent prostate cancer who were scanned, and based on the pattern of recurrence, resulted in a change in management after the scan in 59 percent of the patients.” {read more here}

The group reaffirmed PET’s potential positive contributions to joint disease patients, but warned further research is needed to ultimately decide its clinical application.

“Inflammatory or infectious arthropathies have long posed a diagnostic dilemma, with significant potential morbidity and complications for patients with delayed or incorrect diagnosis,” researchers wrote.

“PET can aid in the early diagnosis of inflammatory or infectious arthropathies and may also be used for the longitudinal monitoring of disease activity for both clinical and research purposes. Potential musculoskeletal applications of PET/MRI remain in the realm of research and need to be expanded in future clinical studies,” they added. {read more here}

Artificial intelligence (AI) software can accurately predict a patient’s gender on PET/CT scans, a capability that could help to avoid patient identification errors in PACS, according to research presented on Saturday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. {read more here}

Researchers from Sweden have developed a fully automated PET spatial normalization method for amyloid-β (Aβ) imaging that may reduce interpretation variability among readers and monitor the effectiveness of patients treated with anti-Aβ drugs—a promising step for Alzheimer’s research. {read more here}